Skip to Content
ON
DEMAND
Subscribe Now
News
Series
Conferences
Insights
Features
MORE
FORTUNE.COM
FORTUNE LIVE MEDIA
FORTUNE CONNECT
Search
SIGN IN
Subscribe Now
Loading...
Series
Why GlaxoSmithKline Won't Do A Merger
December 08, 2015 17:54 PM UTC
- Updated January 31, 2020 12:47 PM UTC
CEO Andrew Witty explains to Fortune's Susie Gharib.
Sections
Leadership
Tags
Merger
On Leading
Leadership
Andrew Witty
GSK
GlaxoSmithKline
Pfizer
Allergan